Related Experiment Videos
A new rating scale for Alzheimer's disease
The American Journal of Psychiatry
|November 1, 1984
Summary
A new Alzheimer's Disease Assessment Scale was developed to measure cognitive and behavioral issues in Alzheimer's patients. This scale effectively differentiates Alzheimer's patients from healthy elderly individuals.
Area of Science:
- Neurology
- Gerontology
- Psychometrics
Background:
- Alzheimer's disease presents with significant cognitive and noncognitive behavioral dysfunctions.
- Accurate assessment tools are crucial for understanding disease severity and progression.
Purpose of the Study:
- To introduce and validate a new rating instrument, the Alzheimer's Disease Assessment Scale (ADAS).
- To evaluate the severity of cognitive and noncognitive behavioral dysfunctions in individuals with Alzheimer's disease.
Main Methods:
- Development of the Alzheimer's Disease Assessment Scale (ADAS) with 40 items.
- Administration and scoring procedures were outlined.
- Reliability assessed using interrater and test-retest correlations in 27 Alzheimer's patients and 28 controls.
Main Results:
- The final ADAS scale consists of 21 items with high interrater reliability (range, .650-.989).
- Test-retest reliability was also significant (range, .514-1).
- Alzheimer's disease subjects exhibited significantly greater cognitive and noncognitive dysfunction compared to normal elderly subjects.
Conclusions:
- The Alzheimer's Disease Assessment Scale (ADAS) is a reliable and valid instrument for assessing Alzheimer's disease severity.
- The scale can effectively distinguish between individuals with Alzheimer's disease and healthy elderly individuals based on cognitive and behavioral deficits.